儿童全身麻醉后苏醒期躁动风险量表的开发与验证:一项前瞻性观察研究
该两阶段研究基于既往120例患儿数据用logistic回归构建预测七氟烷麻醉后苏醒期躁动(EA)的风险量表,并在100例择期小手术患儿中前瞻性验证。量表含年龄、儿科麻醉行为评分、麻醉时间和手术类型4个预测因子,分值1–23分;验证队列EA发生率为39%,c-index为0.81(95%CI 0.72–0.89),最佳切点11分(敏感度87%、特异度61%)。
要点
- 儿童七氟烷麻醉后EA风险量表含4个预测因子,总分1–23分。
- 验证队列c-index为0.81(95%CI 0.72–0.89),预测性能良好。
- 最佳切点11分,敏感度87%、特异度61%,灰色区10–13分含38%患儿。
核心结论
- 开发并验证了用于七氟烷麻醉患儿的EA风险量表,验证队列c-index>0.8,预测性能优异。
- 该量表可用于预测儿童EA并对高危患儿采取预防策略。
研究设计与样本
- 两阶段研究:第一阶段对既往研究120例患者数据行logistic回归分析构建预测模型。
- 第二阶段为前瞻性观察性队列研究,用另外100例择期小手术全身麻醉患儿数据验证量表。
主要发现
- 第一阶段最终多变量logistic回归模型纳入4个预测因子:年龄(对数OR -0.38,95%CI -0.81至0.00)、儿科麻醉行为评分(对数OR 0.65,95%CI -0.09至1.40)、麻醉时间(对数OR 0.60,95%CI -0.18至1.19)、手术操作(斜视手术对数OR 2.53,95%CI 1.30–3.75;扁桃体切除术对数OR 2.71,95%CI 0.99–4.45)。
- EA风险量表包含上述4个预测因子,分值范围1–23分。
- 第二阶段EA发生率为39%,第一阶段c-index为0.84(95%CI 0.74–0.94),第二阶段c-index为0.81(95%CI 0.72–0.89)。
- EA风险量表最佳切点为11分(敏感度87%、特异度61%),灰色区为10–13分,包含38%的患者。
关键数值与推荐
- EA风险量表总分1–23分,最佳切点11分,敏感度87%、特异度61%。
- 灰色区10–13分,包含38%的患者。
临床怎么用
- 该量表可用于预测儿童七氟烷麻醉后EA,并对高危患儿采取预防策略。
- 基于评分的预防策略需前瞻性研究评估其安全性和有效性。
局限性
- 基于评分的预防策略尚需前瞻性研究评估其安全性和有效性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Emergence agitation (EA) is a common complication in children after general anesthesia. The goal of this 2-phase study was (1) to develop a predictive model (EA risk scale) for the incidence of EA in children receiving sevoflurane anesthesia by performing a retrospective analysis of data from our previous study (phase 1) and (2) to determine the validity of the EA risk scale in a prospective observational cohort study (phase 2). METHODS: Using data collected from 120 patients in our previous study, logistic regression analysis was used to predict the incidence of EA in phase 1. The optimal combination of the predictors was determined by a stepwise selection procedure using Akaike information criterion. The β-coefficient for the selected predictors was calculated, and scores for predictors determined. The predictive ability of the EA risk scale was assessed by a receiver operating characteristic (ROC) curve, and the area under the ROC curve (c-index) was calculated with a 95% confidence interval (CI). In phase 2, the validity of the EA risk scale was confirmed using another data set of 100 patients (who underwent minor surgery under general anesthesia). The ROC curve, the c-index, the best cutoff point, and the sensitivity and specificity at the point were calculated. In addition, we calculated the gray zone, which ranges between the two points where sensitivity and specificity, respectively, become 90%. RESULTS: In phase 1, the final model of the multivariable logistic regression analysis included the following 4 predictors: age (logarithm odds ratios [OR], -0.38; 95% CI, -0.81 to 0.00), Pediatric Anesthesia Behavior score (logarithm OR, 0.65; 95% CI, -0.09 to 1.40), anesthesia time (logarithm OR, 0.60; 95% CI, -0.18 to 1.19), and operative procedure (logarithm OR, 2.53; 95% CI, 1.30-3.75 for strabismus surgery and logarithm OR, 2.71; 95% CI, 0.99-4.45 for tonsillectomy). The EA risk scale included these 4 predictors and ranged from 1 to 23 points. In phase 2, the incidence of EA was 39%. The c-index of phase 1 was 0.84 (95% CI, 0.74-0.94), and the c-index of phase 2 was 0.81 (95% CI, 0.72-0.89). The best cutoff point for the EA risk scale was 11 (sensitivity = 87% and specificity = 61%). The gray zone ranged from 10 to 13 points, and included 38% of patients. CONCLUSIONS: We developed and validated an EA risk scale for children receiving sevoflurane anesthesia. In our validation cohort, this scale has excellent predictive performance (c-index > 0.8). The EA risk scale could be used to predict EA in children and adopt a preventive strategy for those at high risk. This score-based preventive approach should be studied prospectively to assess the safety and efficacy of such a strategy.
引用
- Hino M, Mihara T, Miyazaki S, et al. Development and Validation of a Risk Scale for Emergence Agitation After General Anesthesia in Children: A Prospective Observational Study. Anesth Analg. 2017. PMID: 28614125. doi:10.1213/ANE.0000000000002126
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。